Franklin Biotechnology Discovery Fund Advisor (FTDZX)
175.12
-0.51
(-0.29%)
USD |
Mar 06 2026
FTDZX Asset Allocations & Exposures
Asset Allocation
As of January 31, 2026.
| Type | % Net |
|---|---|
| Cash | -0.45% |
| Stock | 98.50% |
| Bond | 0.00% |
| Convertible | 0.00% |
| Preferred | 0.80% |
| Other | 1.15% |
Market Capitalization
As of January 31, 2026
| Large | 33.18% |
| Mid | 13.77% |
| Small | 53.05% |
Region Exposure
| Americas | 78.05% |
|---|---|
|
North America
|
78.05% |
| Canada | 1.06% |
| United States | 76.99% |
|
Latin America
|
0.00% |
As of January 31, 2026. Region breakdown data is
calculated by using the long position holdings of the portfolio.
| Greater Europe | 19.93% |
|---|---|
| United Kingdom | 3.35% |
|
Europe Developed
|
16.58% |
| Denmark | 3.34% |
| France | 2.57% |
| Germany | 0.25% |
| Ireland | 4.57% |
| Netherlands | 5.22% |
| Sweden | 0.16% |
| Switzerland | 0.48% |
|
Europe Emerging
|
0.00% |
|
Africa And Middle East
|
0.00% |
| Greater Asia | 0.00% |
|---|---|
| Japan | 0.00% |
|
Australasia
|
0.00% |
|
Asia Developed
|
0.00% |
|
Asia Emerging
|
0.00% |
| Unidentified Region | 2.01% |
|---|
Stock Sector Exposure
| Cyclical |
|
0.00% |
| Materials |
|
0.00% |
| Consumer Discretionary |
|
0.00% |
| Financials |
|
0.00% |
| Real Estate |
|
0.00% |
| Sensitive |
|
0.00% |
| Communication Services |
|
0.00% |
| Energy |
|
0.00% |
| Industrials |
|
0.00% |
| Information Technology |
|
0.00% |
| Defensive |
|
97.86% |
| Consumer Staples |
|
0.00% |
| Health Care |
|
97.86% |
| Utilities |
|
0.00% |
| Not Classified |
|
2.14% |
| Non Classified Equity |
|
0.86% |
| Not Classified - Non Equity |
|
1.28% |
As of January 31, 2026
Stock Style Exposure
| Large Cap Value | -- |
| Large Cap Core | -- |
| Large Cap Growth | -- |
| Mid Cap Value | -- |
| Mid Cap Core | -- |
| Mid Cap Growth | -- |
| Small Cap Value | -- |
| Small Cap Core | -- |
| Small Cap Growth | -- |